Home › Erdheim-Chester Disease › New York › New York City
Erdheim-Chester Disease clinical trials in New York City, NY
6 studies for Erdheim-Chester Disease are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
ECD-Score: a Study on Erdheim-Chester Disease
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
RecruitingEarly phase 1
- Memorial Sloan Kettering Cancer Center, New York
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
International Rare Histiocytic Disorders Registry (IRHDR)
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center, New York
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.